Small Molecules
15 March 2018
BioCryst Announces Initiation of the Phase 3 APeX-2 Trial of BCX7353 in Patients with Hereditary Angioedema15 March 2018
Auris Medical Provides Business Update13 March 2018
Proteostasis Therapeutics Announces FDA Grants Breakthrough Therapy Designation for PTI-428 in Cystic Fibrosis12 March 2018
Precision Neuroscience Company Cadent Therapeutics Initiates Phase 1 Study of Lead Compound CAD-18838 March 2018
GSK Announces Positive EU Approval for Labelling Update to Relvar Ellipta in Patients with Asthma8 March 2018
Eisai Co., Ltd. and Merck Enter Global Strategic Oncology Collaboration for LENVIMA® (lenvatinib mesylate)7 March 2018
Esperion Announces Positive Top-Line Results from First Pivotal Phase 3 Study of Bempedoic Acid7 March 2018
Boehringer Ingelheim and Lilly expand heart failure program for Jardiance® with new exercise capacity trialsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports